Clinical Trials Directory

Trials / Unknown

UnknownNCT01781663

Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
56 (estimated)
Sponsor
Kamedis Ltd. · Industry
Sex
All
Age
2 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this study is to demonstrate the safety and efficacy of KAM2904 Face Cream and KAM3008 Body Lotion in reducing the symptoms of mild to moderate AD. Efficacy will be evaluated by comparing SCORAD and Eczema Area Severity Index (EASI) in a group of subjects treated with KAM2904 Face Cream and KAM3008 Body Lotion (the treatment group), versus a group of subjects treated with a petrolatum-based moisturizer (the control group). Safety will be determined by the number and severity of Adverse Events Device-Related.

Conditions

Interventions

TypeNameDescription
DEVICEKAM2904 Face Cream
DEVICEKAM3008 Body Lotion
OTHERpetrolatum-based moisturizer

Timeline

Start date
2013-02-01
Primary completion
2014-06-01
First posted
2013-02-01
Last updated
2014-01-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01781663. Inclusion in this directory is not an endorsement.